Inventions, Patents and Socio-Economic Growth

1. Invention, innovation and growth

Economists distinguish invention (a new idea or device), innovation (its first commercial use) and diffusion (its spread through the economy). Joseph Schumpeter, in Capitalism, Socialism and Democracy (1942), described innovation as “creative destruction”: new products and processes displace old ones and drive long-run growth. Robert Solow's growth model (1957) found that most growth in output per worker in the US could not be explained by more capital or labour and must come from technical change. Later endogenous growth theory (Paul Romer, 1990) treated knowledge as the product of deliberate investment in research, and so something policy can encourage. The common point: sustained growth depends on new technology, and a country's capacity to generate and absorb it.

2. Significance in specific terms

• Productivity and industry. New processes lower costs; new products open markets. Green revolution varieties, the Indian generic drug industry and India's IT services all rest on absorbing and adapting technology.
• Health. Vaccines and medicines raise life expectancy and labour productivity; Indian manufacturers' role in supplying low-cost HIV and COVID-19 medicines shows the link between domestic technology and public health.
• Employment and exports. High-technology sectors create skilled jobs and foreign exchange.
• Self-reliance and security. Defence, space and energy depend on domestic technical capacity. Sections 4 and 35 of the Patents Act (atomic energy and secrecy directions) show the State's interest in strategic inventions.
• Social problems. Frugal innovation for low-income users (cheap diagnostics, water purification) addresses needs that markets elsewhere ignore.

3. How patents are meant to help

1. Incentive. The exclusive right lets the inventor recover the cost of research, which competitors would otherwise copy at little cost.
2. Disclosure. The specification must describe the invention fully and the best method of performing it (s.10). After twenty years the knowledge is free; even during the term it informs others' research.
3. Commercialisation. Patents make technology tradeable: a firm can license or sell it, raise capital against it, and attract investors.
4. Technology transfer. Foreign firms are more willing to license or invest where their technology is protected.

4. The evidence and the critiques

The incentive argument is strongest where research is costly and copying is cheap, as in pharmaceuticals and chemicals. Surveys of firms (Mansfield, 1986; the Yale and Carnegie Mellon surveys of the 1980s and 1990s) found that in most other industries lead time, secrecy and learning curves matter more than patents. Fritz Machlup's 1958 study for the US Senate concluded that, if there were no patent system, it would be irresponsible to recommend one, but since there was, it would be irresponsible to abolish it. Michele Boldrin and David Levine (Against Intellectual Monopoly, 2008) argue that patents slow innovation in many fields. Concerns in developed systems include patent thickets (overlapping rights that block follow-on work), evergreening (extending protection by minor changes), and patent assertion entities that license by litigation threat.

For a developing country the special concern is that most patents are held by foreign firms. Unless the patent is worked locally, it may simply give an import monopoly, raising prices without bringing technology. This was the finding that shaped Indian law.

5. India's experience

• 1856 to 1970. The first patent law (Act VI of 1856) and the Indian Patents and Designs Act, 1911 were modelled on British law. By the 1950s the great majority of Indian patents were held by foreigners and very few were worked in India.
• The Ayyangar Report (1959). Justice N. Rajagopala Ayyangar's Report on the Revision of the Patents Law found that the patent system had been used by foreign firms to block local industry, particularly in food, medicines and chemicals. It recommended process-only patents for those fields, shorter terms, and strong compulsory licensing.
• The 1970 Act. For food, drugs and chemicals only processes were patentable, for seven years from filing or five from sealing, whichever was shorter; licences of right; and a working requirement. The Indian pharmaceutical industry developed by reverse engineering and became a world supplier of generics.
• TRIPS and 2005. India had to introduce product patents in all fields, which it did in 2005 after the transition period, while keeping safeguards: s.3(d), pre-grant opposition, compulsory licensing including for export (s.92A), and the working requirement (s.83, s.146).
• After 2005. The National IPR Policy (2016) set the slogan “Creative India; Innovative India”, promoted awareness and faster examination, and reduced fees for startups and MSMEs. The Patents (Amendment) Rules, 2024 shortened timelines and simplified working statements. Filings by Indian residents have risen sharply in recent years, according to the Office of the Controller General's annual reports.

6. The legal tools that tie patents to growth

Section 83 states the general principles: patents are granted to encourage inventions and to secure that they are worked in India on a commercial scale to the fullest extent reasonably practicable without undue delay; they are not granted merely to enable patentees to enjoy a monopoly for the importation of the patented article; they should contribute to the promotion of technological innovation and the transfer and dissemination of technology; and they should not impede public health and nutrition. These principles are used in compulsory licence cases (Natco v. Bayer, 2012) and track TRIPS Articles 7 and 8. Other tools: the s.3 exclusions, government use (s.100), revocation in the public interest (s.66), and limits on restrictive licence terms (s.140).

How this is examined

Q1 of 2024. Write: invention and growth (Schumpeter, Solow), five areas of significance, the four functions of patents, the critique, India's history with the Ayyangar Report and the 2005 shift, and s.83 as the conclusion. Avoid statistics unless you are sure of the official figure.